new fda ruling on tirzepatide Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's decision to restrict compounding pharmacies from producing tirzepatide, the FDA Crackdown Puts Pressure on

If avoiding needles is non-negotiable, drops or lozenges provide alternatives

As weve made progress in understanding how weight loss drugs work, weve recognized that there is a complementary mechanism to those based on GLP-1 agonists

Beyond semaglutide response prediction, the genetic test reveals underlying metabolic vulnerabilities related to hunger signaling, fat storage (FTO variants), and melanocortin pathway function

You cant build more of other organs in your body but you can build more muscle

H., Mosterd, A

Symptoms are commonly mild to moderate, and many patients report a reduction in severity after the initial escalation phase, although delayed gastric emptying can persist to some degree